Sustained Viral Response (SVR)
/ Rapid Virologic Response (RVR)
/ Early Viral Response (EVR)
/ End of Treatment Response (EOT)

Rapid Viral Response and Sustained Treatment Outcome: A Comparison between 2 HCV RNA Assays - 8/05/2008

Eight Weeks of Pegylated Interferon plus Ribavirin for Genotype 2 Chronic HCV Patients with Rapid Virological Response (RVR) - 8/05/2008

74 Percent of Genotype 1 HCV Patients in Experimental HCV PI Boceprevir Phase II Study Achieve Sustained Virologic Response (SVR) at 48 Weeks - 8/05/2008

Telaprevir plus Pegylated Interferon and Ribavirin Produces Rapid Response and Is Well Tolerated in 28-day Study - 7/22/08

Adequate Ribavirin Exposure after the First Dose Predicts Sustained Virological Response to Hepatitis C Treatment in Genotype 1 Patients - 7/08/08

HCV Genotype 1 Patients with High Viral Load Do Better with 48 vs 24 Weeks of Treatment, despite Rapid Virological Response - 7/04/08

European Commission Approves Shorter 16-week Course of Pegasys plus Ribavirin for Rapid Responders with HCV Genotypes 2 or 3 and Low Viral Load - 7/04/08

Sustained Response to Interferon-based Therapy Reduces the Likelihood of Type 2 Diabetes - 6/24/08

Sustained Response to Interferon-based Therapy Reduces the Likelihood of Type 2 Diabetes - 6/24/08

Sustained Virological Response to Pegylated Interferon Alfa-2b (PegIntron) with or without Ribavirin Predicts Continued Response through 5 Years - 5/30/08

Very Early Response to Interferon-based Therapy for Hepatitis C Is Apparent within the First 24 Hours - 5/30/08

Duration of Pegylated Interferon plus Ribavirin May Be Tailored Based on Early Response - 1/04/08

Induction with High-dose Pegylated Interferon alfa-2a (Pegasys) Is More Effective than Standard Dosing for Achieving Rapid and Early Virological Response: The CHARIOT Study - 11/20/07

Virological Response and Safety Outcomes in Chronic Hepatitis C Patients Treated with Pegylated Interferon plus Taribavirin (Viramidine)   - 8/10/07

72-week Treatment with Pegylated Interferon plus Ribavirin Can Produce Sustained Virological Response in Some Prior Relapsers    - 6/15/07

Does Attainment of Sustained Virologic Response (SVR) from Treatment of HCV Constitute a Cure?    - 6/01/07

A Follow-up Week 12 Viral Count Is Useful in Predicting SVR and Is 100% Accurate in Patients without Cirrhosis    - 6/01/07

Statins Improve Sustained Response to Interferon-based Therapy in Small Study - 5/25/07

Does Attainment of Sustained Virologic Response (SVR) from Treatment of HCV Constitute a Cure?   - 5/20/07